STOCK TITAN

LIVN Insider Notice: 1,500 RSU Shares to be Sold via Merrill Lynch

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

LivaNova PLC (LIVN) submitted a Form 144 notice reporting a proposed sale of 1,500 ordinary shares through Merrill Lynch with an aggregate market value of $84,750. The shares were acquired on 06/29/2021 upon vesting of a restricted stock unit award granted under the issuer's equity compensation plan. The filer indicates the approximate date of sale as 08/25/2025 and the intended exchange is NASDAQ. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer and references Rule 144 and Rule 10b5-1 trading plan considerations.

Positive

  • Full disclosure of required Rule 144 details including acquisition date, acquisition method, broker, quantity, aggregate value, and intended sale date
  • Securities were granted under the issuer's equity compensation plan, and the filing identifies the grant date and nature of acquisition

Negative

  • None.

Insights

TL;DR Routine Rule 144 notice for vested equity; disclosure aligns with required insider-sale procedures.

The filing documents a typical compliant Rule 144 notification for the sale of restricted-stock-derived shares. It specifies acquisition method (vesting), acquisition date, broker, quantity, aggregate value, and intended sale date and exchange, which are the core elements required for transparency. The inclusion of the seller's representation regarding material non-public information is standard and important for regulatory protection.

TL;DR Small, routine equity disposal by an insider; unlikely to be market-moving given disclosed size.

The notice reports a proposed disposal of 1,500 shares with an aggregate value of $84,750. Given the context of this being a sale of vested RSUs and the absence of other recent sales reported in the past three months, this appears to be a routine liquidity event rather than a strategic change. The filing supplies necessary execution details (broker and exchange) to facilitate orderly processing.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does LivaNova's Form 144 (LIVN) report?

The form reports a proposed sale of 1,500 ordinary shares acquired via RSU vesting on 06/29/2021, with an aggregate market value of $84,750.

When is the approximate sale date listed on the Form 144?

The filer indicates an approximate sale date of 08/25/2025 on the NASDAQ exchange through Merrill Lynch.

How were the shares acquired according to the filing?

The shares were acquired through the vesting of a restricted stock unit award granted by LivaNova PLC, with acquisition and grant on 06/29/2021.

Did the filer report any other securities sold in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Does the Form 144 include any representation about material non-public information?

Yes. The signer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed and references 10b5-1 plan considerations.
Livanova Plc

NASDAQ:LIVN

View LIVN Stock Overview

LIVN Rankings

LIVN Latest News

LIVN Latest SEC Filings

LIVN Stock Data

3.41B
54.49M
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United Kingdom
LONDON